Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
    • IPOs
  • inderesTV
  • Portfolio
  • Forum
  • Discovery
  • Q&A
  • About Us
    • Our Coverage
    • Team

Prostatype Genomics

0.81 SEK

+1.00 %

Less than 1K followers

PROGEN

First North Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Valuation
Income statement

Income statement

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Prostatype Genomics

2019202020212022202320242025
Revenue0.10.70.00.71.40.20.6
growth-%823.0 %-98.5 %6,700.0 %100.0 %-85.3 %197.0 %
EBITDA-7.7-15.8-15.5-26.8-37.4-38.9-36.8
EBIT-7.9-15.9-15.5-28.7-39.3-40.9-38.9
Profit before taxes-8.5-17.4-15.6-29.1-41.4-41.1-44.5
Net income-8.5-17.4-15.6-29.1-41.4-41.1-44.5
EPS-33.80-68.86-54.03-69.35-89.08-3.32-1.32
Dividend0.000.000.000.000.000.000.00
Dividend ratio-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %

Profitability and return on capital

2019202020212022202320242025
EBITDA-%-10,414.9 %-2,308.1 %-154,600.0 %-3,939.7 %-2,747.8 %-19,435.0 %-6,187.0 %
EBIT-%-10,623.0 %-2,329.9 %-155,480.0 %-4,219.1 %-2,886.0 %-20,425.0 %-6,555.2 %
ROE-100.0 %-61.5 %-43.5 %-111.2 %-168.0 %-122.6 %-167.8 %
ROI-48.6 %-51.7 %-38.9 %-94.0 %-84.2 %-97.8 %-87.5 %
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.